reserpine, combinations

North America

Canada (0)
No result.
United States (3)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
DRALSERP 25MG;0.1MG tabs
N
oral
C02AA52
SERPASIL-APRESOLINE 25MG;0.1MG tabs
N
oral
C02AA52
SERPASIL-APRESOLINE 50MG;0.2MG tabs
N
oral
C02AA52
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
DRALSERP 25MG;0.1MG tabs
84617/1
ANDA
01-01-1982
SERPASIL-APRESOLINE 25MG;0.1MG tabs
9296/4
NDA
01-01-1982
SERPASIL-APRESOLINE 50MG;0.2MG tabs
9296/2
NDA
01-01-1982
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Europe

Austria (0)
No result.
Belgium (0)
No result.
Bosnia and Herzegovina (0)
No result.
Croatia (0)
No result.
Czechia (0)
No result.
Denmark (0)
No result.
Finland (0)
No result.
Hungary (0)
No result.
Iceland (0)
No result.
Ireland (0)
No result.
Lithuania (0)
No result.
Malta (0)
No result.
Netherlands (0)
No result.
Norway (0)
No result.
Poland (0)
No result.
Romania (0)
No result.
Slovenia (0)
No result.
Spain (0)
No result.
Sweden (0)
No result.
Switzerland (0)
No result.